OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies.
Healthcare Focus
The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease.
These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. We believe the healthcare industry’s powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.
Our Strategies
OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.
Private Equity
OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders. We invest globally, including across North America, Asia, and Europe.
Private Credit/Royalty
OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, OrbiMed can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.
Public Equity
OrbiMed manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. We invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide.
Firm History
To thrive, organisms need to adapt and grow. So do investment firms. Through 25 years of volatile, changing investment environments, we've embraced new opportunities and expanded our global footprint.
1989
OrbiMed's investment business was founded in New York City
1993
Launched our first long/ short fund and made
our first venture capital investment
2000
Launched our first dedicated venture capital fund
2007
Opened offices in San Francisco and Shanghai, China
2010
Opened office in Herzliya, Israel
2011
Launched our first dedicated royalty/credit fund
2015
Hired our 100th employee
2017
Opened office in Hong Kong
2023
Opened office in London
Investing with Impact
We seek companies focused on responsible, sustainable growth to build long-term shareholder value, as outlined in our Responsible Investing Policy.
Delivering New Cures
Over 60 new healthcare therapies have been successfully developed and brought to patients by OrbiMed’s venture capital portfolio companies.
Solving the Greatest Needs
OrbiMed has committed over $2 billion to invest in developing-country healthcare, from maternal care hospitals in India to dialysis centers in China.
Starting New Companies
OrbiMed has backed over 90 life sciences start-ups, pushing the boundaries of medicine to achieve breakthroughs for patients.
Making a Difference
Through a charitable matching program and paid time off for community service, we empower team members to become positive changemakers in their communities.
